Precision Medicine News and Updates | Precision Medicine Online
WEBThe plan, announced in January, would reclassify many Class III in vitro diagnostic devices as Class II, impacting companion diagnostic and infectious disease tests. Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.
Precision Oncology News - Precision Medicine Online
WEBGuardant Health Liquid Biopsy CDx Gets Japanese Regulatory Approval for Janssen Lung Cancer Drug. Aug 30, 2024. Hackensack Meridien Health Launches Cancer Risk, Early Detection Program; Eyes Multi-Cancer Testing. Aug 29, 2024. MOMA Therapeutics Advances Cancer Drugs Interrogating Cell Molecular Machinery Into Clinic. Aug 29, 2024.
Precision Medicine Diagnostics
WEBBioNexus Gene Lab, Shenzhen Rongguang Team up on Cancer Screening, Precision Medicine Programs. Sep 13, 2024. AbbVie's Telisotuzumab Vedotin Effective in NSCLC Patients With High, Intermediate c-MET Expression. Sep 12, 2024. Cancer Centers Look to New NGS-Based 'Frankenpanel' to Get Fast Info on Clinically Actionable Genes.
Disease Research & Diagnostics News | Precision Medicine Online
WEBNews and analysis on disease research and diagnostics from Precision Medicine Online.
Breaking News - Precision Medicine Online
WEBSep 13, 2024 · IN8bio to Lay off Nearly Half of Workforce, Narrow Pipeline Focus on AML Cell Therapy. The firm is dropping two glioblastoma programs and cutting 49 percent of its staff to advance its gamma delta T-cell therapy INB …
Precision Oncology in 2022: New Drugs and Tests Amid Ongoing …
WEBJan 4, 2023 · NEW YORK – Looking back at 2022, plenty of new CAR T-cell, radioligand, and biomarker-defined treatments entered the market, as did new tissue and liquid biopsy tests to identify cancer patients eligible for these therapies.
Genomics Technology, Tools & Methods - Precision Medicine Online
WEBNovartis' Scemblix Bests Gleevec, Second-Generation TKIs in Frontline CML. The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics from Precision Medicine Online.
Regulatory News & FDA Approvals | Precision Medicine Online
WEBFoundation Medicine Nets FDA Approval for Tissue, Liquid NGS CDx for Lynparza Combo. The FDA approved FoundationOne CDx and FoundationOne Liquid for identifying BRCA1/2-mutated mCRPC patients eligible for Lynparza, Zytiga, …
Disease Research for Precision Medicine | Precision Medicine Online
WEBSep 9, 2024 · Foundation Medicine, Syndax Pharmaceuticals Partner to Develop CDx for AML Treatment. Load More. Breaking News. News on disease research and therapeutic development trends in precision medicine from Precision Medicine Online.
Breaking News - Precision Medicine Online
WEBUnder the agreement, the companies aim to discover new drug targets in cardiovascular and renal diseases using Quotient's cell phenotyping and genomic sequencing platform.